CV
Clarus Ventures Portfolio holdings
AUM
$425M
This Quarter Return
-11.49%
1 Year Return
+28.76%
3 Year Return
+73.84%
5 Year Return
+169.94%
10 Year Return
–
AUM
$143M
AUM Growth
+$143M
(-18%)
Cap. Flow
-$8.65M
Cap. Flow
% of AUM
-6.06%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
$8.65M |
Sector Composition
| 1 | Healthcare | 98.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
1
DELISTED
NanoString Technologies, Inc.
NSTG
| $58.2M | 40.82% |
3,959,440
| – | – |
|
|
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $24.8M | 17.35% |
2,153,092
| – | – |
|
3
Astria Therapeutics
ATXS
$349M
| $21.8M | 15.3% |
2,752,488
| – | – |
|
|
SIEN
4
DELISTED
Sientra, Inc.
SIEN
| $16.2M | 11.33% |
2,730,765
| – | – |
|
|
VBIV
5
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $12.1M | 8.5% |
4,971,091
| – | – |
|
|
TLOG
6
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
| $8.04M | 5.63% |
4,644,705
| – | – |
|
|
AERI
7
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.53M | 1.08% |
63,017
| – | – |
|
|
EVFM
8
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| – | – |
-1,071,429
| Closed | -$8.65M |
|